332 related articles for article (PubMed ID: 28153676)
1. A model to estimate cost-savings in diabetic foot ulcer prevention efforts.
Barshes NR; Saedi S; Wrobel J; Kougias P; Kundakcioglu OE; Armstrong DG
J Diabetes Complications; 2017 Apr; 31(4):700-707. PubMed ID: 28153676
[TBL] [Abstract][Full Text] [Related]
2. The accuracy and cost-effectiveness of strategies used to identify peripheral artery disease among patients with diabetic foot ulcers.
Barshes NR; Flores E; Belkin M; Kougias P; Armstrong DG; Mills JL
J Vasc Surg; 2016 Dec; 64(6):1682-1690.e3. PubMed ID: 27575813
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Lower Extremity Nerve Decompression Surgery in the Prevention of Ulcers and Amputations: A Markov Analysis.
Rinkel WD; Franks B; Birnie E; Castro Cabezas M; Coert JH
Plast Reconstr Surg; 2021 Nov; 148(5):1135-1145. PubMed ID: 34705790
[TBL] [Abstract][Full Text] [Related]
4. Illustration of Cost Saving Implications of Lower Extremity Nerve Decompression to Prevent Recurrence of Diabetic Foot Ulceration.
Rankin TM; Miller JD; Gruessner AC; Nickerson DS
J Diabetes Sci Technol; 2015 Jul; 9(4):873-80. PubMed ID: 26055081
[TBL] [Abstract][Full Text] [Related]
5. A Cost-Effectiveness Analysis Comparing Single-use and Traditional Negative Pressure Wound Therapy to Treat Chronic Venous and Diabetic Foot Ulcers.
Kirsner RS; Delhougne G; Searle RJ
Wound Manag Prev; 2020 Mar; 66(3):30-36. PubMed ID: 32294054
[TBL] [Abstract][Full Text] [Related]
6. Geographic variation in Medicare spending and mortality for diabetic patients with foot ulcers and amputations.
Sargen MR; Hoffstad O; Margolis DJ
J Diabetes Complications; 2013; 27(2):128-33. PubMed ID: 23062327
[TBL] [Abstract][Full Text] [Related]
7. Reducing the incidence of foot ulceration and amputation in diabetes.
Bartus CL; Margolis DJ
Curr Diab Rep; 2004 Dec; 4(6):413-8. PubMed ID: 15539004
[TBL] [Abstract][Full Text] [Related]
8. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations.
Ragnarson Tennvall G; Apelqvist J
Diabetologia; 2001 Nov; 44(11):2077-87. PubMed ID: 11719840
[TBL] [Abstract][Full Text] [Related]
9. Policy evaluation in diabetes prevention and treatment using a population-based macro simulation model: the MICADO model.
van der Heijden AA; Feenstra TL; Hoogenveen RT; Niessen LW; de Bruijne MC; Dekker JM; Baan CA; Nijpels G
Diabet Med; 2015 Dec; 32(12):1580-7. PubMed ID: 26010494
[TBL] [Abstract][Full Text] [Related]
10. Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs.
Hicks CW; Selvarajah S; Mathioudakis N; Sherman RE; Hines KF; Black JH; Abularrage CJ
Ann Vasc Surg; 2016 May; 33():149-58. PubMed ID: 26907372
[TBL] [Abstract][Full Text] [Related]
11. The health care costs of diabetic peripheral neuropathy in the US.
Gordois A; Scuffham P; Shearer A; Oglesby A; Tobian JA
Diabetes Care; 2003 Jun; 26(6):1790-5. PubMed ID: 12766111
[TBL] [Abstract][Full Text] [Related]
12. Foot problems in diabetes.
Slovenkai MP
Med Clin North Am; 1998 Jul; 82(4):949-71. PubMed ID: 9706128
[TBL] [Abstract][Full Text] [Related]
13. Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments.
Redekop WK; Stolk EA; Kok E; Lovas K; Kalo Z; Busschbach JJ
Diabetes Metab; 2004 Dec; 30(6):549-56. PubMed ID: 15671925
[TBL] [Abstract][Full Text] [Related]
14. Tibial nerve decompression for the prevention of the diabetic foot: a cost-utility analysis using Markov model simulations.
Sarmiento S; Pierre JA; Dellon AL; Frick KD
BMJ Open; 2019 Mar; 9(3):e024816. PubMed ID: 30878982
[TBL] [Abstract][Full Text] [Related]
15. The costs of diabetic foot: the economic case for the limb salvage team.
Driver VR; Fabbi M; Lavery LA; Gibbons G
J Vasc Surg; 2010 Sep; 52(3 Suppl):17S-22S. PubMed ID: 20804928
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective.
Su HY; Yang CY; Ou HT; Chen SG; Chen JC; Ho HJ; Kuo S
JAMA Netw Open; 2023 Jan; 6(1):e2250639. PubMed ID: 36633847
[TBL] [Abstract][Full Text] [Related]
17. Diabetic foot ulcer management in clinical practice in the UK: costs and outcomes.
Guest JF; Fuller GW; Vowden P
Int Wound J; 2018 Feb; 15(1):43-52. PubMed ID: 29243399
[TBL] [Abstract][Full Text] [Related]
18. Cost of managing complications resulting from type 2 diabetes mellitus in Canada.
O'Brien JA; Patrick AR; Caro JJ
BMC Health Serv Res; 2003 Mar; 3(1):7. PubMed ID: 12659641
[TBL] [Abstract][Full Text] [Related]
19. Medical strategies to reduce amputation in patients with type 2 diabetes.
Malik RA; Tesfaye S; Ziegler D
Diabet Med; 2013 Aug; 30(8):893-900. PubMed ID: 23445087
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France.
Maunoury F; Oury A; Fortin S; Thomassin L; Bohbot S;
PLoS One; 2021; 16(1):e0245652. PubMed ID: 33481840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
